{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011342","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2025-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.092883+00:00","generated_at":"2026-05-18T03:38:40.571263+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Anebulo plans going-private via reverse split; $3.50/share for fractional shares, 91% premium","bullets":["Reverse stock split ratio range 1-for-2,500 to 1-for-7,500; stockholder vote at special meeting Aug 22, 2025.","Cash payment of $3.50 per pre-split share for fractional shares, representing a 91% premium to July 22 close.","Holders below 2,500-7,500 pre-split shares will be cashed out; holders above retain one post-split share per minimum.","Transaction aims to reduce record holders below 300 to terminate SEC registration; board may abandon at any time.","Company cites high cost of being public as burdensome; will focus on advancing selonabant IV formulation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011342","json":"https://secwatch.observer/filing/0001493152-25-011342.json","markdown":"https://secwatch.observer/filing/0001493152-25-011342.md","text":"https://secwatch.observer/filing/0001493152-25-011342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315225011342/0001493152-25-011342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315225011342/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T03:38:40.571263+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}